Covance Inc. (NYSE: CVD) today announced that Edgar Adams, Sc.D has joined the Company as Executive Director of Epidemiology, with responsibility for providing scientific and technical leadership across Covance’s epidemiology, clinical outcomes, and risk management services. With increasing regulatory and public scrutiny on biopharmaceutical product safety, this move strengthens the leadership team for Covance’s portfolio of services to help biopharmaceutical firms proactively address signal detection, risk minimization and pharmacovigilance from the earliest stages of development, through to patient access to approved products.
